Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2011-03-21

FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

This document notes an FDA supplemental application for LEVOXYL (levothyroxine sodium) submitted by Pfizer Laboratories Div Pfizer Inc, generally indicating a l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOXYL (LEVOTHYROXINE SODIUM)

Snippet

SUPPL AP for LEVOXYL (LEVOTHYROXINE SODIUM)